Efficacy of Pemetrexed as Second-line Therapy or Beyond in Patients 
with Advanced Non-small Cell Lung Cancer

Efficacy of Pemetrexed as Second-line Therapy or Beyond in Patients 
with Advanced Non-small Cell Lung Cancer

Background and objective Pemetrexed is a standard second-line therapy in advanced non-small cell lung cancer (NSCLC). Currently, cytotoxic treatments beyond second-line therapy are not available. This study evaluated the efficacy and safety of pemetrexed as a salvage regimen in heavily pretreated pa...

Full description

Bibliographic Details
Main Authors: Junling LI, Jing WANG, Xuezhi HAO, Xiangru ZHANG, Yuankai SHI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2012-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Pemetrexed
Chemotherapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2012.03.08

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2012.03.08

Similar Items